Weight loss program with or without semaglutide for teens with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 17 years old.
- You have been diagnosed with obesity (BMI at least 2 standard deviations above average for your age and sex).
- You are already enrolled in the Growing Health Weight Management or Next Step pediatric clinic and have at least one year left in the program.
- You are not using certain medications, such as antidepressants, anxiety drugs, or diabetes medications.
- You do not have type 1 or type 2 diabetes, pancreatitis, or a history of eating disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This study tests a medication called semaglutide (a once-a-week injection) to help teenagers with autism who have obesity lose weight and improve their body composition. It compares their results to a group of similar teens who didn't take the drug.
This trial tests if restarting semaglutide (a weekly injection for weight loss) soon after sleeve gastrectomy helps teens with severe obesity keep losing weight. It is for patients who were already taking semaglutide before their surgery.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.